MENU
JUNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Jupiter Neurosciences (JUNS) Ownership - Who owns Jupiter Neurosciences?
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
42.7M
P/E Ratio
N/A
Total Cash
2.71M
Projected Growth
N/A
Total Debt
205.5K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.08
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
JUNS
Capitalization
42.7M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.71M
Total Cash/Share
0.08
Total Debt
205K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.07M
P/B Ratio
13.93
Cash Flow
N/A
Earnings
-0.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.31K
Current Ratio
1.91
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-3.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-131.28
Shares Held By Institutions
240K
Shares Outstanding - Current
33.1M
Total Liabilities
1.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-87.944
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. JUNS showed earnings on May 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information